Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CorMedix Inc. Director's Dealing 2010

Nov 30, 2010

32333_dirs_2010-11-30_1b9e85cf-6d3c-49d4-b2f9-a75995e51a56.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CorMedix Inc. (CRMD)
CIK: 0001410098
Period of Report: 2010-11-26

Reporting Person: Houser Mark T. (Chief Medical Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-11-26 Common Stock, $0.001 par value per share P 5000 $1.2980 Acquired 52832 Direct